Premium
Commentary: efficacy and safety of ribavirin plus pegylated interferon‐alpha in geriatric patients with chronic hepatitis C
Author(s) -
Hadziyannis S. J.,
Sevastianos V.
Publication year - 2013
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/apt.12175
Subject(s) - medicine , ribavirin , discontinuation , hepatitis c , pegylated interferon , context (archaeology) , hepatitis c virus , population , clinical trial , cirrhosis , incidence (geometry) , life expectancy , immunology , virus , paleontology , physics , environmental health , optics , biology